ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

TRDA Entrada Therapeutics Inc

13.16
-0.40 (-2.95%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Entrada Therapeutics Inc TRDA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.40 -2.95% 13.16 09:00:00
개장가 저가 고가 종가 전일 종가
13.70 12.92 13.91 13.16 13.56
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
13/03/202420:00GLOBEEntrada Therapeutics Reports Fourth Quarter and Full Year..
09/03/202406:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202406:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:22EDGAR2Form 144 - Report of proposed sale of securities
07/03/202406:22EDGAR2Form 144 - Report of proposed sale of securities
06/03/202409:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202421:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
03/01/202421:16EDGAR2Form 8-K - Current report
03/01/202421:00GLOBEEntrada Therapeutics Promotes Nathan J. Dowden to President
27/12/202306:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202306:26EDGAR2Form 144 - Report of proposed sale of securities
06/12/202321:00EDGAR2Form 8-K - Current report
23/11/202301:56DJNEntrada Therapeutics Shares Tumble 27% After FDA Keeps..
22/11/202321:54DJNEntrada: FDA Declines to Lift Hold on Duchenne Study
22/11/202321:35EDGAR2Form 8-K - Current report
22/11/202321:00GLOBEEntrada Therapeutics Announces Updates on ENTR-601-44 in..
07/11/202321:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:08EDGAR2Form 8-K - Current report
07/11/202321:00GLOBEEntrada Therapeutics Reports Third Quarter 2023 Financial..
01/11/202320:01EDGAR2Form 8-K - Current report
12/10/202320:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
30/09/202305:39EDGAR2Form 8-K - Current report
30/09/202305:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/09/202320:09EDGAR2Form 8-K - Current report
21/09/202320:00GLOBEEntrada Therapeutics Announces First Participant Dosed in..
07/09/202320:00GLOBEEntrada Therapeutics Awards Funding to Non-Profit..
07/09/202306:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202306:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202306:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202306:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202305:09EDGAR2Form 144 - Report of proposed sale of securities
07/09/202305:09EDGAR2Form 144 - Report of proposed sale of securities
07/09/202305:08EDGAR2Form 144 - Report of proposed sale of securities
06/09/202305:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202305:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/08/202320:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
10/08/202320:09EDGAR2Form 8-K - Current report
10/08/202320:00GLOBEEntrada Therapeutics Appoints Gina Chapman to its Board of..
08/08/202320:25EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
08/08/202320:23EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
08/08/202320:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202320:07EDGAR2Form 8-K - Current report
08/08/202320:00GLOBEEntrada Therapeutics Reports Second Quarter 2023 Financial..
05/08/202305:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/08/202305:10EDGAR2Form 144 - Report of proposed sale of securities
01/08/202320:08EDGAR2Form 8-K - Current report
01/08/202320:00GLOBEEntrada Therapeutics Receives Authorization in the United..
13/07/202305:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

Delayed Upgrade Clock